Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.
Journal: Cephalalgia : an international journal of headache
Published: May 28, 2022
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.
Journal: Headache
Published: March 23, 2021
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
Journal: BMC neurology
Published: March 15, 2020
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
Journal: BMC neurology
Published: September 10, 2019
Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: April 13, 2017
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: May 16, 2015
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
Journal: Journal of clinical psychopharmacology
Published: March 28, 2015
Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
Journal: Drugs in context
Published: February 04, 2015
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
Journal: The Journal of clinical psychiatry
Published: October 29, 2014
Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine.
Journal: Journal of child and adolescent psychopharmacology
Published: July 15, 2014
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: May 13, 2014
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: May 13, 2014
Last Updated: 09/26/2026